期刊论文详细信息
Journal of Experimental & Clinical Cancer Research
Knockdown of the nucleosome binding protein 1 inhibits the growth and invasion of clear cell renal cell carcinoma cells in vitro and in vivo
Li-Qun Zhou2  Xue-Song Li1  Xiao-Yu Zhang1  Lin Yao1  Shi-Qi Ji1 
[1] National Urological Cancer Center, Beijing 100034, China;Department of Urology, First Hospital of Peking University, Peking University, No. 8, Xishiku Street, West District, Beijing 100034, China
关键词: MMPs;    Cell cycle;    Apoptosis;    NSBP1;    Clear cell renal cell carcinoma;   
Others  :  826746
DOI  :  10.1186/1756-9966-31-22
 received in 2012-02-09, accepted in 2012-03-15,  发布年份 2012
PDF
【 摘 要 】

Background

The nucleosome binding protein 1 (HMGN5/NSBP1) is a member of the HMGN protein family and is highly expressed in several kinds of cancer. Nevertheless, the role of NSBP1 in clear cell renal cell carcinoma (ccRCC) remains unclear. This study aimed to confirm the oncogenic role of NSBP1 in ccRCC using in vitro and in vivo models and explore the mechanism by which NSBP1 contributes to ccRCC tumorigenesis.

Methods

NSBP1 expression was detected in renal tissues from 152 ccRCC patients by immunohistochemistry, and examined in ccRCC cell lines by RT-PCR and Western blot analysis. ccRCC cells were transfected by NSBP1 RNAi and cell viability, apoptosis and invasion were detected by cell vitality test, flow cytometry and transwell assay in vitro. Xenograft in nude mice was also employed to examine the tumorigenesis of ccRCC cells depleted of NSBP1.

Results

Immunohistostaining showed strong immunoreactivity of NSBP1 in all ccRCC tissues and NSBP1 expression level was associated with tumor grade (p = 0.04). NSBP1 expression at mRNA and protein levels was high in ccRCC cell lines. Knockdown of NSBP1 induced cell cycle arrest and apoptosis, and inhibited invasion in 786-O cells. Western blot analysis demonstrated increased expression of Bax and decreased expression of Bcl-2, CyclinB1, VEGF, VEGFR-2, MMP-2, MMP-9, c-fos and c-jun in 786-O cells depleted of NSBP1. In vivo study further showed that knockdown of NSBP1 affected the tumorigenesis of ccRCC cells in nude mice.

Conclusions

NSBP1 plays oncogenic role in ccRCCs by promoting cell proliferation and invasion, and could be exploited as a target for ccRCC treatment.

【 授权许可】

   
2012 Ji et al; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140713102753587.pdf 1064KB PDF download
Figure 4. 46KB Image download
Figure 3. 49KB Image download
Figure 2. 48KB Image download
Figure 1. 41KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】
  • [1]Ljungberg B, Campbell SC, Choi HY, Jacqmin D, Lee JE, Weikert S, Kiemeney LA: The epidemiology of renal cell carcinoma. Eur Urol 2011, 60:615-621.
  • [2]Hock R, Furusawa T, Ueda T, Bustin M: HMG chromosomal proteins in development and disease. Trends Cell Biol 2007, 17:72-79.
  • [3]Wang JW, Zhou LQ, Yang XZ, Ai JK, Xin DQ, Na YQ, Guo YL: The NSBP1 expression is up-regulated in prostate cancer cell. Basic Med Sci Clin 2004, 24:393-397.
  • [4]Huang C, Zhou LQ, Song G: Effect of nucleosomal binding protein 1 in androgen-independent prostatic carcinoma. Zhong hua Yi Xue Za Zhi 2008, 88:657-660.
  • [5]Green J, Ikram M, Vyas J, Patel N, Proby CM, Ghali L, Leigh IM, O'Toole EA, Storey A: Overexpression of the Axl tyrosine kinase receptor in cutaneous SCC-derived cell lines and tumours. Br J Cancer 2006, 94:1446-1451.
  • [6]Li DQ, Hou YF, Wu J, Chen Y, Lu JS, Di GH, Ou ZL, Shen ZZ, Ding J, Shao ZM: Gene expression profile analysis of an isogenic tumour metastasis model reveals a functional role for oncogene AF1Q in breast cancer metastasis. Eur J Cancer 2006, 42:3274-3286.
  • [7]Tang WY, Newbold R, Mardilovich K, Jefferson W, Cheng RY, Medvedovic M, Ho SM: Persistent hypomethylation in the promoter of nucleosomal binding protein1 (Nsbp1) correlates with overexpression of Nsbp1 in mouse uteri neonatally exposed to diethylstilbestrol or genistein. Endocrinology 2008, 149:5922-5931.
  • [8]Zhou LQ, Song G, He ZS, Hao JR, Na YQ: Effect of inhibiting nucleosomal binding protein 1 on proliferation of human prostate cancer cell line LNCaP. Chin Med J 2007, 86:404-408.
  • [9]Jiang N, Zhou LQ, Zhang XY: Downregulation of the nucleosome-binding protein 1 (NSBP1) gene can inhibit the in vitro and in vivo proliferation of prostate cancer cells. Asian J Androl 2010, 12:709-717.
  • [10]Mukherjee S, Roth MJ, Dawsey SM, Yan W, Rodriguez-Canales J, Erickson HS, Hu N, Goldstein AM, Taylor PR, Richardson AM, Tangrea MA, Chuaqui RF, Emmert-Buck MR: Increased matrix metalloproteinase activation in esophageal squamous cell carcinoma. J Transl Med 2010, 8:91. BioMed Central Full Text
  • [11]Rak J, Milsom C, May L, Klement P, Yu J: Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy. Semin Thromb Hemost 2006, 32:54-70. Review
  • [12]Rochman M, Malicet C, Bustin M: HMGN5/NSBP1: A new member of the HMGN protein family that affects chromatin structure and function. Biochim Biophys Acta 2010, 1799:86-92.
  • [13]Shirakawa H, Herrera JE, Bustin M, Postnikov Y: Targeting of high mobility group-14/-17 proteins in chromatin is independent of DNA sequence. J Biol Chem 2000, 275:37937-37944.
  • [14]Catez F, Lim JH, Hock R, Postnikov YV, Bustin M: HMGN dynamics and chromatin function. Biochem Cell Biol 2003, 81:113-122.
  • [15]Rochman M, Postnikov Y, Correll S, Malicet C, Wincovitch S, Karpova TS, McNally JG, Wu X, Bubunenko NA, Grigoryev S, Bustin M: The interaction of NSBP1/HMGN5 with nucleosomes in euchromatin counteracts linker histone-mediated chromatin compaction and modulates transcription, Mol. Cell 2009, 35:642-656.
  • [16]Rattner BP, Yusufzai T, Kadonaga JT: HMGN proteins act in opposition to ATP-dependent chromatin remodeling factors to restrict nucleosome mobility. Mol Cell 2009, 34:620-626.
  • [17]Rozenblat S, Grossman S, Bergman M, Gottlieb H, Cohen Y, Dovrat S: Induction of G2/M arrest and apoptosis by sesquiterpene lactones in human melanoma cell lines. Biochem Pharmacol 2008, 75:369-382.
  • [18]Beauman SR, Campos B, Kaetzel MA, Dedmana JR: CyclinB1 expression is elevated and mitosis is delayed in HeLa cells expressing autonomous CaMKII. Cell Signal 2003, 15:1049-1057.
  • [19]Chulu JuliusLC, Huang Wei R, Wang L, Shih Wen L, Liu Hung J: Avian Reovirus Nonstructural Protein p17-Induced G2/M Cell Cycle Arrest and Host Cellular Protein Translation Shutoff Involve Activation of p53-Dependent Pathways. J Virol 2010, 84:7683-7694.
  • [20]Yin J, Chen G, Liu Y, Liu S, Wang P, Wan Y, Wang X, Zhu J, Gao H: Downregulation of SPARC expression decreases gastric cancer cellular invasion and survival. J Exp Clin Cancer Res 2010, 29:59. BioMed Central Full Text
  • [21]Rink M, Chun FK, Robinson B, Sun M, Karakiewicz PI, Bensalah K, Fisch M, Scherr DS, Lee RK, Margulis V, Shariat SF: Tissue-based molecular markers for renal cell carcinoma. Minerva Urol Nefrol 2011, 63:293-308.
  • [22]Chang HR, Chen PN, Yang SF, Sun YS, Wu SW, Hung TW, Lian JD, Chu SC, Hsieh YS: Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel. Mol Carcinog 2011, 50:811-823.
  文献评价指标  
  下载次数:8次 浏览次数:17次